Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $266.61 | 11 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Boston Scientific Corporation | $108.71 | 4 | $0 (2024) |
| LeMaitre Vascular, Inc. | $89.74 | 4 | $0 (2022) |
| SI-BONE, Inc. | $28.06 | 1 | $0 (2022) |
| PAINTEQ LLC | $22.08 | 1 | $0 (2024) |
| Collegium Pharmaceutical, Inc. | $18.02 | 1 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $44.95 | 2 | Boston Scientific Corporation ($22.87) |
| 2023 | $103.86 | 4 | Boston Scientific Corporation ($85.84) |
| 2022 | $58.90 | 3 | LeMaitre Vascular, Inc. ($30.84) |
| 2021 | $58.90 | 2 | LeMaitre Vascular, Inc. ($58.90) |
All Payment Transactions
11 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 08/23/2024 | Boston Scientific Corporation | WaveWriter Alpha Prime 16 (Device) | Food and Beverage | In-kind items and services | $22.87 | General |
| Category: WaveWriter Alpha_NMD | ||||||
| 05/18/2024 | PAINTEQ LLC | PAINTEQ (Device) | Food and Beverage | In-kind items and services | $22.08 | General |
| Category: PAIN MANAGEMENT | ||||||
| 07/19/2023 | Boston Scientific Corporation | WaveWriter Alpha Prime 16 (Device) | Food and Beverage | In-kind items and services | $23.95 | General |
| Category: WaveWriter Alpha_NMD | ||||||
| 05/12/2023 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $38.91 | General |
| Category: General - Therapies_NMD | ||||||
| 05/03/2023 | Collegium Pharmaceutical, Inc. | Belbuca (Drug) | Food and Beverage | Cash or cash equivalent | $18.02 | General |
| Category: Opioid Analgesic | ||||||
| 03/16/2023 | Boston Scientific Corporation | WaveWriter Alpha Prime 16 (Device) | Food and Beverage | In-kind items and services | $22.98 | General |
| Category: WaveWriter Alpha_NMD | ||||||
| 11/17/2022 | SI-BONE, Inc. | — | Food and Beverage | Cash or cash equivalent | $28.06 | General |
| 08/02/2022 | LeMaitre Vascular, Inc. | ANASTOCLIP GC 8CM (MEDIUM) (Device) | Food and Beverage | Cash or cash equivalent | $20.94 | General |
| Category: ANASTOCLIP | ||||||
| 06/22/2022 | LeMaitre Vascular, Inc. | ARTEGRAFT VASCULAR GRAFT (Device) | Food and Beverage | Cash or cash equivalent | $9.90 | General |
| Category: ARTEGRAFT | ||||||
| 09/14/2021 | LeMaitre Vascular, Inc. | ANASTOCLIP (Device) | Food and Beverage | Cash or cash equivalent | $17.57 | General |
| Category: ANASTOCLIP | ||||||
| 05/06/2021 | LeMaitre Vascular, Inc. | ANASTOCLIP (Device) | Food and Beverage | Cash or cash equivalent | $41.33 | General |
| Category: ANASTOCLIP | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 18 | 1,371 | 4,124 | $1.5M | $330,197 |
| 2022 | 8 | 453 | 671 | $315,685 | $58,959 |
| 2021 | 1 | 105 | 108 | $167,856 | $20,164 |
| 2020 | 1 | 99 | 102 | $148,931 | $19,679 |
All Medicare Procedures & Services
28 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 245 | 954 | $398,708 | $84,464 | 21.2% |
| 80307 | Testing for presence of drug, by chemistry analyzers | Office | 2023 | 270 | 1,088 | $190,400 | $66,160 | 34.7% |
| G0482 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | Office | 2023 | 134 | 199 | $148,056 | $38,613 | 26.1% |
| G0481 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | Office | 2023 | 112 | 197 | $113,866 | $30,232 | 26.6% |
| 64493 | Injection of lower or sacral spine facet joint using imaging guidance, single level | Office | 2023 | 62 | 107 | $119,524 | $19,819 | 16.6% |
| 64635 | Destruction of lower or sacral spinal facet joint nerves using imaging guidance, single facet joint | Office | 2023 | 36 | 37 | $53,449 | $17,204 | 32.2% |
| 62323 | Injection of substance into lower spine canal using imaging guidance | Office | 2023 | 63 | 77 | $64,788 | $13,535 | 20.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 116 | 116 | $62,872 | $13,043 | 20.7% |
| 64494 | Injection of lower or sacral spine facet joint using imaging guidance, second level | Office | 2023 | 62 | 107 | $63,352 | $10,350 | 16.3% |
| 64636 | Destruction of lower or sacral spinal facet joint nerves using imaging guidance, each additional facet joint | Office | 2023 | 36 | 37 | $58,650 | $9,296 | 15.8% |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | Office | 2023 | 55 | 81 | $32,481 | $8,882 | 27.3% |
| 64454 | Injection of anesthetic agent and/or steroid into knee nerve branch using imaging guidance | Office | 2023 | 21 | 34 | $23,777 | $6,960 | 29.3% |
| 64624 | Destruction of nerve branches of knee using imaging guidance | Office | 2023 | 14 | 18 | $23,292 | $4,884 | 21.0% |
| 62321 | Injection of substance into middle or upper spine canal using imaging guidance | Office | 2023 | 17 | 18 | $15,474 | $3,311 | 21.4% |
| 64417 | Injection of anesthetic agent and/or steroid into upper arm and shoulder nerve (axillary nerve) | Office | 2023 | 13 | 23 | $10,274 | $2,636 | 25.7% |
| 64418 | Injection of anesthetic agent and/or steroid into suprascapular shoulder nerve | Office | 2023 | 13 | 23 | $6,650 | $704.02 | 10.6% |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | Office | 2023 | 76 | 965 | $119,875 | $74.91 | 0.1% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 26 | 43 | $1,290 | $29.01 | 2.2% |
| 01844 | Anesthesia for placement or revision of blood flow shunt | Facility | 2022 | 81 | 86 | $130,888 | $16,046 | 12.3% |
| 80307 | Testing for presence of drug, by chemistry analyzers | Office | 2022 | 124 | 195 | $34,125 | $11,776 | 34.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 105 | 117 | $48,906 | $10,921 | 22.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 69 | 69 | $37,398 | $8,416 | 22.5% |
| G0482 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | Office | 2022 | 34 | 36 | $26,784 | $7,012 | 26.2% |
| 62323 | Injection of substance into lower spine canal using imaging guidance | Office | 2022 | 15 | 15 | $12,570 | $2,779 | 22.1% |
| G0481 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | Office | 2022 | 11 | 13 | $7,514 | $1,995 | 26.6% |
About Dr. Todd Besselievre, M.D
Dr. Todd Besselievre, M.D is a Anesthesiology healthcare provider based in Batesville, Arkansas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/09/2005. The National Provider Identifier (NPI) number assigned to this provider is 1679554323.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Todd Besselievre, M.D has received a total of $266.61 in payments from pharmaceutical and medical device companies, with $44.95 received in 2024. These payments were reported across 11 transactions from 5 companies. The most common payment nature is "Food and Beverage" ($266.61).
As a Medicare-enrolled provider, Besselievre has provided services to 2,028 Medicare beneficiaries, totaling 5,005 services with total Medicare billing of $428,999. Data is available for 4 years (2020–2023), covering 28 distinct procedure/service records.
Practice Information
- Specialty Anesthesiology
- Other Specialties Interventional Pain Medicine
- Location Batesville, AR
- Active Since 11/09/2005
- Last Updated 09/30/2025
- Taxonomy Code 207L00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1679554323
Products in Payments
- WaveWriter Alpha Prime 16 (Device) $69.80
- ANASTOCLIP (Device) $58.90
- PAINTEQ (Device) $22.08
- ANASTOCLIP GC 8CM (MEDIUM) (Device) $20.94
- Belbuca (Drug) $18.02
- ARTEGRAFT VASCULAR GRAFT (Device) $9.90
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Anesthesiology Doctors in Batesville
Christopher Steel, Md, MD
Anesthesiology — Payments: $27,222
Dr. Carol Mccourt, M.d, M.D
Anesthesiology — Payments: $1,574
Wyatt Lydolph
Anesthesiology — Payments: $201.77
Dr. Sergio Bisono, M.d, M.D
Anesthesiology
Dr. Luis Flores, M.d, M.D
Anesthesiology
Enoch Brown, Md, MD
Anesthesiology